...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Why now?

trading the OTC listing is dangerous in my opinion.  Yes it is a trading vehicle but I see them as virtual shares that are not linked to real Zenith capital Corp shares.  

If the end game for Zenith is a buyout and they come to an agreement to sell, the OTC shares are entitiled to no payout.  Wouldn't they quickly go to $0 value in that scenario?

 

Share
New Message
Please login to post a reply